Ustekinumab (Stelara ™) and Breastfeeding
Ustekinumab is a disease modifying, biological drug used to treat psoriatic arthritis, plaque psoriasis, Crohns disease, and ulcerative colitis. It is given by sub cutaneous injection. It has a molecular weight 149,000, poor oral bioavailability and milk plasma ratio 0.001 – 0.027 Ustekinumab is a recombinant human monoclonal TNF antibody that binds specifically to TNF- […]
Adalimumab (Humira™) and Breastfeeding
Adalimumab is a disease modifying, biological drug used to treat rheumatoid arthritis, psoriatic arthritis, Crohns disease, ulcerative colitis and Hidradenitis suppurativa. It is given by sub cutaneous injection. It has a molecular weight 148,000. Poor oral bioavailability and relative infant dose 0.12% ( well below 10% regarded as compatible). Adalimumab is a recombinant human monoclonal […]